To investigate the molecular mechanisms of CML initiation and evolution, we collected PBMC samples from the CP CML mice at sequential time points after BCR::ABL induction by tetracycline discontinuation (Tet-off; Fig. 1A). This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.